STAT3 and lung cancer: STAT3 has been reported to be associated with the survival rate of patients with nonsmall cell lung cancer (Sun et al., 2018) and AKT has been associated with survival rate in esophageal cancer (Shan, Chen, Wang, Wang, & Fan, 2017).